Anatomy and Function of the Prostate Gland

The prostate is a walnut-sized exocrine gland located below the bladder and anterior to the rectum in males. It produces seminal fluid, which nourishes and transports sperm. Prostate cancer adenocarcinoma arises from glandular epithelial cells and accounts for approximately 95% of all prostate cancers. In India, prostate cancer is the second most common cancer among men, with an estimated 40,000 new cases annually (ICMR 2025 data).

Clinical Significance of Early Detection

Early-stage prostate adenocarcinoma is often asymptomatic. However, when detected early (localized to the prostate), the 5-year survival rate exceeds 99%. Delayed diagnosis allows the cancer to metastasize to bones and lymph nodes, reducing survival to 30% at 5 years. The advantages of early detection include:

• Curative Treatment Options: Radical prostatectomy, radiation therapy, or active surveillance are viable.
• Reduced Morbidity: Early intervention minimizes urinary and sexual side effects.
• Cost-Effective Management: Early-stage treatment is less expensive than advanced-stage therapy.

Symptomatology of Prostate Adenocarcinoma

Symptoms typically manifest when the tumor compresses the urethra or invades adjacent structures. The following table outlines common symptoms and their clinical significance:

Less common symptoms include painful ejaculation and unexplained weight loss. Any persistent urinary or sexual health change warrants a clinical evaluation.

Risk Mitigation and Screening Recommendations

While age (≥50 years), family history, and genetic mutations (BRCA1/2, HOXB13) are non-modifiable, lifestyle modifications can reduce risk. The following strategies are evidence-based:

• Dietary Patterns: High intake of lycopene (tomatoes), selenium, and vitamin E may lower risk; avoid excessive calcium.
• Physical Activity: Regular exercise improves immune function and reduces inflammation.
• Smoking Cessation: Smoking is associated with aggressive prostate cancer.
• Alcohol Moderation: Limit to ≤2 drinks/day.

Screening Protocols (2026 Guidelines)

The American Urological Association recommends shared decision-making for men aged 50–69 with average risk. For high-risk men (African ancestry, family history, BRCA mutations), screening begins at age 40–45. Screening includes:

• PSA Blood Test: Elevated PSA (>4 ng/mL) prompts further evaluation.
• Digital Rectal Exam (DRE): Detects palpable nodules.
• Multiparametric MRI: Used for risk stratification before biopsy.

Genetic Testing and Precision Oncology

Hereditary prostate cancer accounts for 5–10% of cases. Germline mutations in BRCA1, BRCA2, HOXB13, and mismatch repair genes increase risk. DNA Labs India offers comprehensive genetic panels using Next-Generation Sequencing (NGS) and Whole Exome Sequencing (WES) to identify these mutations. This information guides screening intensity and targeted therapies (e.g., PARP inhibitors for BRCA-mutated tumors).

Note: Genetic testing is recommended for men with a strong family history (≥2 first-degree relatives) or early-onset disease (≤55 years). Pre-test genetic counseling is mandatory.

Diagnostic Services at DNA Labs India

As an ISO 9001 certified lab, DNA Labs India provides accurate and timely diagnostics. Our services include:

• PSA Testing: Chemiluminescent immunoassay with 24-hour TAT.
• Genetic Panels: Hereditary prostate cancer panel (BRCA1/2, HOXB13, MLH1, MSH2) using NGS.
• Whole Exome Sequencing: For comprehensive hereditary cancer risk assessment.

All tests are performed with strict quality controls and interpreted by board-certified pathologists.